PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.50
Bid: 67.00
Ask: 80.00
Change: 3.50 (5.00%)
Spread: 13.00 (19.403%)
Open: 70.00
High: 73.50
Low: 65.00
Prev. Close: 70.00
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

28 Sep 2011 07:00

RNS Number : 0540P
Feedback PLC
28 September 2011
 



28 September 2011

Feedback plc

("Feedback" or "the Company")

 

Proposed subscription to raise £272,500

 

Feedback is pleased to announce that it has raised £272,500 (the "Subscription") through the issue of 21,800,000 new ordinary shares in the capital of the Company at a subscription price of 1.25 pence per share (the "Subscription Shares") to certain Directors of the Company, Institutional and other investors.

 

Certain directors of the Company have agreed to subscribe for an aggregate of 10,158,755 Subscription Shares as part of the Subscription. The respective subscriptions, together with the resultant holdings in the enlarged issued share capital are as follows:

 

No. of Subscription Shares

Shareholding following Admission

Percentage holding of enlarged issued share capital

David Barton, Non-executive Director*

2,621,204

15,744,871

12.02

John Westcott, Non-executive Director**

1,537,551

5,999,287

4.58

Nick Shepheard, Executive Chairman

5,000,000

5,000,000

3.82

Mark Bird, Group Sales Director

1,000,000

1,000,000

0.76

 

*David Barton's holding includes 2,250,000 ordinary shares held by Huntley Securities Pension Fund of which Mr Barton is the sole beneficiary.

** - includes 3,548,748 ordinary shares held by his wife.

 

In addition, Tom Charlton, a substantial shareholder of the Company, has agreed to subscribe for 2,600,000 Subscription Shares. Following Admission, Mr Charlton will be beneficially interested in a total of 19,238,397 ordinary shares, equivalent to 14.69 per cent. of the enlarged issued share capital of the Company.

 

The Directors' aggregated participation in the Subscription constitutes a related party transaction in accordance with the AIM Rules. In accordance with Rule 13 of the AIM Rules, David John Marks ("the Independent Director"), having consulted with Merchant Securities Limited, the Company's Nominated Adviser, considers the terms of the Subscription to be fair and reasonable insofar as the shareholders of the Company are concerned. In advising the Independent Director, Merchant Securities Limited has relied upon the commercial assessment of the Independent Director.

 

Application will be made for the Subscription Shares to be admitted to trading on AIM. Admission is expected to become effective and dealings are expected to commence on AIM on 3 October 2011. Following the issue of the Subscription Shares, the Company will have 130,946,746 ordinary shares in issue.

 

For further information contact:

 

Feedback plc

Tel: 01892 653 322

Nick Shepheard

Merchant Securities Limited

Simon Clements/Lindsay Mair

Tel: 020 7628 2200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZMGZLNNFGMZM
Date   Source Headline
30th Jun 201712:41 pmRNSIssue of Equity
8th Jun 20171:15 pmRNSCCI Exclusive Distributor Agreement with Korea ISG
8th Jun 20171:11 pmRNSDirectorate Change
1st Jun 20179:23 amRNSTotal Voting Rights
30th May 20174:38 pmRNSFurther re. Notice of Resignation of Director
18th May 20177:00 amRNSProgress with CE Mark and trading update
12th May 201711:57 amRNSHolding(s) in Company
2nd May 20177:00 amRNSNotice of Resignation of Director
26th Apr 20177:00 amRNSIssue of Equity
30th Mar 20177:00 amRNSLetter of Intent signed and trading update
3rd Mar 20177:00 amRNSAppointment of Joint Broker
20th Feb 20177:00 amRNSHalf-year Report
23rd Jan 20171:28 pmRNSRe: Media Articles
30th Nov 20165:00 pmRNSTotal Voting Rights
24th Nov 201612:44 pmRNSDirector/PDMR Shareholding
23rd Nov 20161:20 pmRNSIssue of Equity & Director / PDMR Shareholding
23rd Nov 201610:33 amRNSResult of AGM
16th Nov 20167:00 amRNSAttendance at RSNA 2016
19th Oct 20163:17 pmRNSRe: Directorate
19th Oct 20167:00 amRNSFinal results for the year ended 31 May 2016
21st Sep 201612:30 pmRNSTrading Update
28th Jul 20161:31 pmRNSCollaboration with Future Processing
1st Jun 201612:30 pmRNSAppointment of Non-Executive Chairman
3rd May 201612:00 pmRNSDisposal
2nd Mar 20167:00 amRNSChange of Nominated Adviser
22nd Feb 20167:00 amRNSInterim Results for the 6 months ended 30 Nov 2015
30th Nov 20152:59 pmRNSResult of AGM
23rd Nov 20157:00 amRNSTexRAD Update
6th Nov 20157:01 amRNSDirectorate Change
6th Nov 20157:00 amRNSFinal Results
8th Oct 20157:00 amRNSStrategy Update
6th Oct 20159:45 amRNSNHS publication on potential application of TexRAD
5th Oct 20157:00 amRNSTexRAD Prostate Cancer Product Development
28th Sep 20157:00 amRNSLicence of TexRAD to Stone Checker
9th Sep 20157:00 amRNSFirst sale of TexRAD in China
31st Jul 20157:00 amRNSTotal Voting Rights
20th Jul 20157:00 amRNSStudy Results
9th Jul 20158:39 amRNSExercise of Options
6th Jul 20152:08 pmRNSIssue of Equity
30th Jun 20157:00 amRNSTotal Voting Rights
12th Jun 20157:00 amRNSFirst server sale of TexRAD in Canada
4th Jun 20159:56 amRNSStmnt re Share Price Movement
3rd Jun 20157:00 amRNSIssue of Equity
15th May 20157:00 amRNSCollaboration with University of Texas
11th May 20153:09 pmRNSPreliminary results from the Oxford Stone Group
29th Apr 20157:00 amRNSDrug Trial and Trading Update
28th Apr 20157:00 amRNSCollaboration with Princess Alexandra Hospital, AU
27th Apr 20157:00 amRNSFirst sale of TexRAD in South Korea
23rd Apr 201512:15 pmRNSStmnt re Share Price Movement
20th Apr 20157:00 amRNSAdoption of TexRAD research software

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.